1 Min Read
March 23 (Reuters) - Cellect Biotechnology Ltd:
* Cellect biotechnology provides corporate update and reports fourth quarter and full year 2016 financial results
* Qtrly loss per share $0.007 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.